Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2026-05-29 @ 12:55 AM
Study NCT ID:
NCT05903092
Status:
RECRUITING
Last Update Posted:
2025-05-04
First Post:
2023-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
Sponsor:
Organization: